On January 8, 2026, Karen Foster, the Chief Quality and Operations Officer of BioLife Solutions, Inc. (the “Company”), provided notice of her decision to retire from her position as Chief Quality and Operations Officer of the Company, effective March 31, 2026. Ms. Foster’s decision to retire from her position with the Company was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. The Company appreciates Ms. Foster’s services to the Company and wishes her the best in retirement.
Metrics
| Valuation | |
|---|---|
| Market cap | $ 1.381B |
| Market cap (USD) | — |
| P/E | 7.76 |
| PEG | — |
| P/BV | 3.29 |
| P/S | — |
| P/OCF | 81.81 |
| P/FCF | 129.79 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -1.3% |
| ROI | -1.2% |
| ROIC | -3.3% |
| Profit margin | -4.8% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | Yes |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 33 |
| Quality score | -41.2% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 96.214M | 82.254M | 143.271M | 161.759M | 119.156M | 48.087M | 27.371M | 19.742M | 11.022M | 8.227M | 6.449M | 6.191M | 8.949M | 5.663M | 2.759M | 2.082M |
| Net profit | -4.595M | -20.184M | -66.427M | -139.805M | -7.635M | 2.667M | -1.657M | 3.266M | -2.515M | -6.875M | -4.214M | -3.218M | -1.084M | -1.66M | -1.957M | -1.984M |
| Free cash flow | 10.637M | 5.204M | -18.879M | -18.873M | -12.978M | 4.684M | 538K | 1.848M | 461.355K | -4.471M | -5.108M | -3.752M | -90.663K | -296.786K | -1.083M | -1.281M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share price | 24.18 | 25.96 | 16.25 | 18.2 | 37.27 | 39.89 | 16.18 | 12.03 | 6 | 1.61 | 2.19 | 1.64 | — | — | — | — |
| Price performance 12m | -0.07 | 0.6 | -0.11 | -0.51 | -0.07 | 1.47 | 0.35 | 1 | 2.73 | -0.26 | 0.33 | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
Company History
Name and ticker changes, and re-registrations under a new regulatory id. When a ticker stopped being used is not recorded, so former tickers are undated.
| Date | Change | Detail |
|---|---|---|
| Aug 6, 2026 | Acquired by | Acquired by Repligen Corporation (CIK 730272). |
| Jan 21, 2004 | Renamed | CRYOMEDICAL SCIENCES INC → BIOLIFE SOLUTIONS INC |
ETFs Holding Biolife Solutions Inc
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.